Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atherosclerotic Cardiovascular Diseases (ASCVD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06471036
What this trial is testing

Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?

Who this might be right for
ASCVDLDL-C
Duke University 400
Not applicableActive Not RecruitingNCT07522645
What this trial is testing

Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease

Who this might be right for
ASCVDDiabetes
Kaiser Permanente 22,000
Not applicableUnknownNCT05434273
What this trial is testing

Effects of Integrated Cardiovascular Health Education Program on Older Adults at Risk of ASCVD

Who this might be right for
Cardiovascular DiseasesHealthy LifestyleHealth Education
The Hong Kong Polytechnic University 190
Post-approval studies (Phase 4)Enrolling By InvitationNCT05579626
What this trial is testing

Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)

Who this might be right for
Pre DiabetesASCVD
Seung-Whan Lee, M.D., Ph.D. 4,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07654231
What this trial is testing

Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD

Who this might be right for
Chronic Kidney Disease Mineral and Bone DisorderHypertensionDiabetes+3 more
University of Texas Southwestern Medical Center 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT07235046
What this trial is testing

DII235 in Adults With Elevated Lipoprotein(a)

Who this might be right for
Lipoprotein Disorder
Novartis Pharmaceuticals 234
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Not applicableLooking for participantsNCT06062394
What this trial is testing

Penn Medicine Healthy Heart

Who this might be right for
HypertensionHyperlipidemias
University of Pennsylvania 1,980
Large-scale testing (Phase 3)Looking for participantsNCT07551492
What this trial is testing

A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Fujian Shengdi Pharmaceutical Co., Ltd. 9,262
Not applicableLooking for participantsNCT07334834
What this trial is testing

Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease

Who this might be right for
Hyperlipidemia
Colorado Prevention Center 100
Testing effectiveness (Phase 2)Looking for participantsNCT07311330
What this trial is testing

Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Erectile Dysfunction
Beijing Inno Medicine Co., Ltd. 40
Large-scale testing (Phase 3)Looking for participantsNCT06875973
What this trial is testing

Pelacarsen Roll-over Extension Program

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 599
Not applicableNot Yet RecruitingNCT07615296
What this trial is testing

Target-Oriented Strategy of Ultra-Low LDL-C (<1.0 vs. 1.0-1.39 mmol/L) in Extreme-High-Risk ASCVD Patients: Clinical Benefit, Safety and Cost-Effectiveness Assessment

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)
Beijing Anzhen Hospital 6,000
Not applicableLooking for participantsNCT05765370
What this trial is testing

LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)

Who this might be right for
Atherosclerotic Cardiovascular DiseaseOlder PatientsLDL Cholesterol
China National Center for Cardiovascular Diseases 4,200
Large-scale testing (Phase 3)Looking for participantsNCT06813911
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals 340
Not applicableUnknownNCT03868332
What this trial is testing

Predictors of Subclinical Atherosclerotic Cardiovascular Diseases (ASCVD) in Patients With Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Diseases
Assiut University 80
Large-scale testing (Phase 3)Study completedNCT02666664
What this trial is testing

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

Who this might be right for
HypercholesterolemiaAtherosclerotic Cardiovascular Diseases
Esperion Therapeutics, Inc. 2,230
Not applicableStudy completedNCT05858879
What this trial is testing

Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD)

Who this might be right for
ASCVDCoronary Artery Calcification
Stanford University 233
Not applicableStudy completedNCT05378529
What this trial is testing

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Who this might be right for
Atherosclerotic Cardiovascular Disease
Amgen 39,480
Testing effectiveness (Phase 2)Looking for participantsNCT07327840
What this trial is testing

Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)

Who this might be right for
Lipoprotein Disorder
Kylonova (Xiamen) Biopharma co., LTD. 204
Next Page